Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymidylate synthase (TS) is a highly conserved enzyme (EC 2.1.1.45) that catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), using 5,10-methylenetetrahydrofolate. This reaction provides the only de novo pathway for dTMP synthesis, which is essential for DNA replication and repair. Overexpression of TS has been observed in various cancers and correlates with poor prognosis and resistance to chemotherapeutic agents. It also has autoregulatory function by interacting with its own mRNA.
Inhibition of thymidylate synthase leads to depletion of dTMP pools causing DNA damage
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymidylate Synthase (None).